Patents Examined by Louise W Humphrey
-
Patent number: 11975034Abstract: The present invention provides for compositions and methods for treating colorectal cancer or for reducing the risk of developing the disease in an individual. More specifically, compositions comprising an effective amount of beneficial bacteria such as Lactobacillus gallinarum, Lactococcus lactis, and Carnobacterium maltaromaticum are provided for the purpose of treating colorectal cancer in a person or for the purpose of reducing a person's risk of later developing colorectal cancer. Corresponding kits and methods are also provided.Type: GrantFiled: August 4, 2022Date of Patent: May 7, 2024Assignee: The Chinese University of Hong KongInventors: Jun Yu, Ka Kei Wu, Qing Li
-
Patent number: 11969461Abstract: The present invention concerns a composition comprising (a) botulinum toxin and (b) non-crosslinked hyaluronic acid and its use of the treatment or prevention of dystonia, spasticity and/or wrinkles. Further, the present invention relates to a method for cosmetically smoothing or preventing wrinkles comprising the step of administering the present composition.Type: GrantFiled: February 28, 2017Date of Patent: April 30, 2024Assignee: MERZ PHARMA GMBH & CO. KGAAInventors: Klaus Fink, Harold Taylor, Hermann Russ, Peter Boderke
-
Patent number: 11932880Abstract: The present invention provides a protein having pentosidine oxidase activity, a method for measuring pentosidine comprising: contacting the protein with a specimen; and detecting a change caused by the contact, and the like.Type: GrantFiled: February 27, 2019Date of Patent: March 19, 2024Assignee: Kikkoman CorporationInventors: Kazuya Marushima, Yuka Saito, Yuki Tsukada, Takuya Sato, Yasuko Araki, Atsushi Ichiyanagi
-
Patent number: 11879123Abstract: Modified probiotics, pharmaceutical compositions thereof, and methods of modulating and treating disorders are disclosed.Type: GrantFiled: June 21, 2018Date of Patent: January 23, 2024Assignee: Synlogic Operating Company, Inc.Inventors: Dean Falb, Adam B. Fisher, Vincent M. Isabella, Jonathan W. Kotula, David Lubkowicz, Paul F. Miller, Yves Millet, Sarah Elizabeth Rowe
-
Patent number: 11839635Abstract: A method against Salmonella typhimurium infection includes using a composition containing cultures of Lactobacillus rhamnosus LRH10 which is deposited at the Deutsche Sammlung von Mikroorganismen and Zellkulturen (DSMZ) GmbH under an accession number DSM 32786, Lactobacillus paracasei LPC12 which is deposited at the DSMZ GmbH under an accession number DSM 32785, Lactobacillus fermentum LF26 which is deposited at the DSMZ GmbH under an accession number DSM 32784, Streptococcus thermophilus ST30 which is deposited at the DSMZ GmbH under an accession number DSM 32788, and Lactobacillus helveticus LH43 which is deposited at the DSMZ GmbH under an accession number DSM 32787.Type: GrantFiled: September 28, 2022Date of Patent: December 12, 2023Assignee: SYNBIO TECH INC.Inventors: Shih-Hsuan Lin, Ai-Hua Hsu, Chia-Chia Lee
-
Patent number: 11826336Abstract: This disclosure relates to nutritional formulas and uses for treating or preventing a gastrointestinal condition and/or motor-planning speech and/or coordinator difficulties. In certain embodiments, this disclosure relates to a nutritional formula comprising medium chain fatty acids, or esters thereof (such as and tri-, di-, mono-glycerides, or alkyl esters), unsaturated fatty acids, and a vitamin E and optionally other nutrients. In certain embodiments, any of the compounds or nutrients may be in alternative salt forms.Type: GrantFiled: June 1, 2021Date of Patent: November 28, 2023Assignees: Emory University, Children's Healthcare of Atlanta, Inc.Inventor: Claudia R. Morris
-
Patent number: 11814757Abstract: A method of forming a substrate includes mapping a three dimensional spatial distribution of at least one structural protein fiber of extracellular matrix of biological material of interest, designing a fiber assembly pattern based on an intrinsic pattern of the at least one structural protein fiber of the extracellular matrix of the biological material, and assembling fibers based on the fiber assembly pattern to form the substrate.Type: GrantFiled: June 15, 2016Date of Patent: November 14, 2023Assignee: BIOCONIX PTY LTD.Inventor: Melissa Knothe Tate
-
Patent number: 11806375Abstract: An algal biomass and supernatant derived from at least one species of algae exhibits the ability to maintain general health in humans and non-human animals and promote a healthy immune system in them. Food, feed and nutritional supplements comprising an algal biomass or supernatant derived from at least one species of algae are described. Methods of maintaining general health or promoting a healthy immune system in humans and non-human animals comprises administering to the animal in need thereof an algal biomass or supernatant derived from at least one species of algae, or an extract, derivative or homeopathic compound derived from the algae species, biomass or supernatant, or a composition thereof.Type: GrantFiled: February 15, 2017Date of Patent: November 7, 2023Assignee: Zivo Bioscience, Inc.Inventors: Andrew A. Dahl, Amy E. Steffek
-
Patent number: 11807847Abstract: The invention belongs to the field of cosmetic biotechnology, and specifically relates to an Enterobacter that degrades hyaluronic acid and a cultivation method and application thereof. The Enterobacter sp. CGJ001 of the present invention was deposited in the China General Microbiological Culture Collection Center on Oct. 10, 2019, and the preservation number is CGMCC NO. 18661. The Enterobacter strain can efficiently produce hyaluronidase, and can be used in the process of preparing low molecular hyaluronic acid and oligomeric hyaluronic acid from high molecular hyaluronic acid. The enzyme has high specificity towards hyaluronic acid, excellent thermal stability and pH stability, and is suitable for large-scale industrial application. Thus, it can replace the traditional hyaluronidase extracted from expensive animal tissues. There should be broad application prospects in the fields of medicine and cosmetics.Type: GrantFiled: August 8, 2022Date of Patent: November 7, 2023Assignee: JIANGNAN UNIVERSITYInventors: Jinsong Shi, Zhenghong Xu, Jinsong Gong, Wei Liu, Hui Li, Jianying Qian, Lei Liu, Qing Li, Mengyi Zhang, Chuanli Kang
-
Patent number: 11807586Abstract: Synthetic compositions comprising a plant element and at least one fungal endophyte are described. The fungal endophyte is capable of improving plant tolerance to biotic stress as compared to a reference plant element not further comprising the endophyte. Examples of biotic stress include the biotic stress caused by a nematode, an aphid, a fleahopper, a lygus bug, a stink bug, a soy looper, a cabbage looper, or a fungus.Type: GrantFiled: December 22, 2017Date of Patent: November 7, 2023Assignee: THE TEXAS A&M UNIVERSITY SYSTEMInventor: Gregory A. Sword
-
Patent number: 11793196Abstract: The present invention relates to a fusion protein having a targeting sequence, exosporium protein, or exosporium protein fragment that targets the fusion protein to the exosporium of a recombinant Bacillus cereus family member and an enzyme having serine protease activity, wherein the enzyme having serine protease activity is from Bacillus firmus or is a variant of such enzyme. The present invention also provides a recombinant Bacillus cereus family member that expresses such fusion protein and exosporium fragments derived from such recombinant Bacillus cereus family member. Methods of using such recombinant Bacillus cereus family members or exosporium fragments derived therefrom for nematode control are also provided.Type: GrantFiled: March 18, 2020Date of Patent: October 24, 2023Assignee: Bayer CropScience LPInventors: Damian Curtis, Kevin Bugg
-
Patent number: 11786601Abstract: A pegylated, circularly permuted construct of the CapD enzyme (a gamma glutamyl transferase enzyme acting as a hydrolase specific to poly-?-D-glutamic acid) is used to treat anthrax and other bacterial infections, including but not limited to infection with strains that are resistant to available antibiotics.Type: GrantFiled: January 18, 2022Date of Patent: October 17, 2023Assignee: The Government of the United States of America, as represented by the Secretary of the NavyInventors: Patricia M. Legler, Arthur M. Friedlander, Jaimee R. Compton
-
Patent number: 11767545Abstract: A microorganism having at least one SPX gene encoding SPX protein responsive to phosphorus deficiency, and characterized in that a function of the SPX protein is decreased or lost by introducing gene mutation into the SPX gene.Type: GrantFiled: September 6, 2019Date of Patent: September 26, 2023Assignees: HIROSHIMA UNIVERSITY, TOKYO INSTITUTE OF TECHNOLOGY, MAZDA MOTOR CORPORATIONInventors: Atsushi Sakamoto, Kumiko Okazaki, Takashi Yamamoto, Hiroyuki Ohta, Koichi Hori, Shinsuke Shimizu, Akihide Takami, Seiji Nomura, Fumihiko Saito
-
Patent number: 11759486Abstract: A method for treating an immune disease caused by a Th1/Th2 imbalance in favor of a Th2 shift in a subject including administering a composition comprising Lactobacillus plantarum CJLP133 strain KCTC 11403BP to the subject in need thereof.Type: GrantFiled: October 21, 2020Date of Patent: September 19, 2023Assignee: CJ CHEILJEDANG CORP.Inventors: Bong Joon Kim, Heon Woong Jung, Se Hee Hwang, Jin Hee Lee, Kang-Pyo Lee, Kwang Woo Hwang, Tae Joon Won
-
Patent number: 11744865Abstract: A composition for inhibiting lipofuscin accumulation or removing lipofuscin is disclosed. A Chryseobacterium sp. strain, a lysate of the Chryseobacterium sp. strain, a culture of the Chryseobacterium sp. strain, or an extract of the lysate or culture is included in the composition. The composition provides an anti-aging effect by inhibiting lipofuscin accumulation or removing lipofuscin. The composition also provides an effect of preventing, ameliorating or treating the diseases caused by the lipofuscin accumulation, such as skin hyperpigmentation, Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, myocardial infarction and age-related macular degeneration.Type: GrantFiled: April 22, 2022Date of Patent: September 5, 2023Assignee: Amorepacific CorporationInventors: Eunmi Kim, Juewon Kim, Si Young Cho, Mihee Ji
-
Patent number: 11746067Abstract: The present invention comprises methods and compositions comprising a microalgae consortium. A composition comprises at least one genera of microalgae flocculated by Paenibacillus polymyxa strain, Strain 2, deposited under the Budapest Treaty as ATCC Accession No. PTA-12841. Methods of treating the soil comprise adding a composition of the present invention to soil.Type: GrantFiled: October 29, 2019Date of Patent: September 5, 2023Assignee: Core Intellectual Properties Holdings, LLCInventors: Luke Blotsky, Karin L. Hastings, Derex Q. Zellars
-
Patent number: 11740249Abstract: Provided herein are compositions and methods for detection and analysis of intracellular binding of a bioactive agent to a cellular target. In particular, bioactive agents tethered to fluorophores, cellular targets fused to bioluminescent reporters, and methods of detecting and analyzing the interaction of bioactive agents with cellular targets therewith.Type: GrantFiled: September 4, 2018Date of Patent: August 29, 2023Assignee: Promega CorporationInventors: Carolyn W. Hitko, Thomas Kirkland, Thomas Machleidt, Rachel Friedman Ohana, Matt Robers, Keith Wood
-
Patent number: 11732277Abstract: A method for producing high purity iron oxide nanoparticles using nanoparticle-producing cells, including: a) a pre-growth step that includes amplifying the nanoparticle-producing cell(s) in a pre-growth and/or fed-batch medium/media, and b) a growth step that includes amplifying the nanoparticle-producing cell(s) originating from the pre-growth step in a growth and/or fed-batch medium/media, wherein the pre-growth and/or growth and/or fed-batch medium/media comprise(s), per kilogram or liter of pre-growth and/or growth and/or fed-batch medium/media: i) no more than 0.005 gram of yeast extract, and ii) no more than 0.001 gram of CMR agent selected from boric acid and nitrilotriacetic acid, wherein the fed-batch medium when it is present is a medium that supplements the pre-growth and/or growth medium/media, and wherein more nanoparticles are produced in the growth step than in the pre-growth step.Type: GrantFiled: October 1, 2019Date of Patent: August 22, 2023Assignee: NANOBACTERTEInventor: Edouard Alphandery
-
Patent number: 11730779Abstract: The present invention provides a lactic acid bacterial composition for inhibiting the activity of Escherichia coli and/or treating or preventing jaundice, the composition including: a Bifidobacterium animalis subsp. lactis CP-9 strain and a Lactobacillus salivarius subsp. salicinius AP-32 strain. The present invention further provides a method for inhibiting growth of Escherichia coli, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof. The present invention additionally provides a method for treating or preventing jaundice, the method including the step(s) of: administering the foregoing lactic acid bacterial composition to a subject in need thereof.Type: GrantFiled: February 11, 2022Date of Patent: August 22, 2023Assignee: GLAC BIOTECH CO., LTDInventors: Hsieh-Hsun Ho, Yi-Wei Kuo, Jia-Hung Lin, Hui-Shan Wang, Yen-Yu Huang, Wen-Yang Lin, Ko-Chiang Hsia
-
Patent number: 11732009Abstract: A nanoparticle activity sensor containing a reporter and at least one tuning domain that modifies a distribution or residence time of the activity sensor when administered to a patient. When administered to the patient, the activity sensor enters cells or tissue where it is cleaved by enzymes specific to a physiological state such as a disease to release a detectable analyte. The tuning domains include molecular structures that modulate distribution or decay by protecting the particle from premature cleavage and indiscriminate hydrolysis, shielding the particle from immune detection and clearance, or by targeting the particle to specific tissue, bodily fluids, or cell types.Type: GrantFiled: March 15, 2019Date of Patent: August 22, 2023Assignee: GLYMPSE BIO, INC.Inventors: Sangeeta Bhatia, Gabriel Kwong, Eric Huang, Sirshendu Roopom Banerjee, Andrew Warren, Sophie Cazanave